Back to results
CompletedPhase 2

Treatment of Alzheimer's Disease With CX516 (Ampalex)

NCT00001662

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

National Institute of Neurological Disorders and Stroke (NINDS)

Bethesda, Maryland, United States

View on ClinicalTrials.gov
Treatment of Alzheimer's Disease With CX516 (Ampalex) — TrialFind